Hypoxic conditioned medium derived from bone marrow mesenchymal stromal cells protects against ischemic stroke in rats
- 4 August 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (2) , 1354-1368
Abstract
In recent years, studies have shown that the secretome of bone marrow mesenchymal stromal cells (BMSCs) contains many growth factors, cytokines, and antioxidants, which may provide novel approaches to treat ischemic diseases. Furthermore, the secretome may be modulated by hypoxic preconditioning. We hypothesized that conditioned medium (CM) derived from BMSCs plays a crucial role in reducing tissue damage and improving neurological recovery after ischemic stroke and that hypoxic preconditioning of BMSCs robustly improves these activities. Rats were subjected to ischemic stroke by middle cerebral artery occlusion and then intravenously administered hypoxic CM, normoxic CM, or Dulbecco modified Eagle medium (DMEM, control). Cytokine antibody arrays and label‐free quantitative proteomics analysis were used to compare the differences between hypoxic CM and normoxic CM. Injection of normoxic CM significantly reduced the infarct area and improved neurological recovery after stroke compared with administering DMEM. These outcomes may be associated with the attenuation of apoptosis and promotion of angiogenesis. Hypoxic preconditioning significantly enhanced these therapeutic effects. Fourteen proteins were significantly increased in hypoxic CM compared with normoxic CM as measured by cytokine arrays. The label‐free quantitative proteomics analysis revealed 163 proteins that were differentially expressed between the two groups, including 107 upregulated proteins and 56 downregulated proteins. Collectively, our results demonstrate that hypoxic CM protected brain tissue from ischemic injury and promoted functional recovery after stroke in rats and that hypoxic CM may be the basis of a potential therapy for stroke patients.Keywords
Funding Information
- China Postdoctoral Science Foundation (2014M560383)
- National Natural Science Foundation of China (81571777)
- National Natural Science Foundation of China (81501565)
- National Natural Science Foundation of China (81771794)
- National Natural Science Foundation of China (81601582)
- National Natural Science Foundation of China (81471764)
This publication has 51 references indexed in Scilit:
- Hypoxic Preconditioning Augments the Therapeutic Efficacy of Bone Marrow Stromal Cells in a Rat Ischemic Stroke ModelCellular and Molecular Neurobiology, 2016
- Repairing the Brain by SCF+G-CSF Treatment at 6 Months Postexperimental StrokeASN Neuro, 2016
- Conditioned Medium Derived from Neural Progenitor Cells Induces Long-term Post-ischemic Neuroprotection, Sustained Neurological Recovery, Neurogenesis, and AngiogenesisMolecular Neurobiology, 2016
- Bone Marrow Endothelial Progenitor Cell Transplantation After Ischemic Stroke: An Investigation Into Its Possible MechanismCNS Neuroscience & Therapeutics, 2015
- Effect of HMGB1 on the Paracrine Action of EPC Promotes Post-Ischemic Neovascularization in MiceStem Cells, 2014
- Effects of Cryopreservation on the Cell Viability, Proliferative Capacity and Neuronal Differentiation Potential of Canine Bone Marrow Stromal CellsJournal of Veterinary Medical Science, 2014
- Therapeutic effects of human adipose stem cell‐conditioned medium on strokeJournal of Neuroscience Research, 2012
- Proliferation Capacity, Neuronal Differentiation Potency and Microstructures after the Differentiation of Canine Bone Marrow Stromal Cells into NeuronsJournal of Veterinary Medical Science, 2012
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass EffectStem Cells and Development, 2009
- Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia PatientPLOS Medicine, 2009